2022
Wellcome Open Res (2022). 10.12688/wellcomeopenres.17735.1.
2022
medRxiv (2022). 10.1101/2022.07.29.22278186.
2022
BMJ, (2022).378, 10.1136/bmj-2021-068946.
2022
British Medical Journal, (2022).378, 10.1136/bmj-2022-071249.
2022
BMC medicine, (2022).20 1 10.1186/s12916-022-02422-0.
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.
2022
BRITISH JOURNAL OF DERMATOLOGY, (2022).187,
2022
The Lancet Rheumatology, (2022).4 7 10.1016/S2665-9913(22)00098-4.
2022
Vaccine, (2022).40 32 10.1016/j.vaccine.2022.06.010.
2022
medRxiv (2022). 10.1101/2022.06.06.22276026.